drugset / Trial / NCT00587431
Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
We postulate that multiple apoptototic events are indusce through testosterone depletion and repletion with taxotere given in conjunction with androgen withdrawal.
Timeline
- Start
- 2003-07
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 70 mg/m2 | — |
| Subject | Leuprolide | Other / unclassified | 22.5 mg | Intramuscular |
| Subject | Testosterone | Small molecule | 7.5 g | Topical |